RT Book, Section A1 Falk, Erling A1 Fuster, Valentin A2 Fuster, Valentin A2 Harrington, Robert A. A2 Narula, Jagat A2 Eapen, Zubin J. SR Print(0) ID 1191187295 T1 ATHEROTHROMBOSIS: DISEASE BURDEN, ACTIVITY, AND VULNERABILITY T2 Hurst's The Heart, 14e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9780071843249 LK accessmedicine.mhmedical.com/content.aspx?aid=1191187295 RD 2024/04/19 AB SummaryThis chapter discusses the pathophysiological development of atherothrombosis. Atherothrombosis is the chronic, lipid-driven, multifocal inflammatory process of atherosclerotic plaque development (see accompanying Hurst’s Central Illustration) and subsequent thrombosis. Individual susceptibility to well-known risk factors for atherothrombosis varies considerable, and better detection of at-risk individuals may be achieved by visualizing the arterial wall. Plaques are very heterogeneous in size and composition. Many plaques remain asymptomatic, some become obstructive, and a few, if any, become vulnerable to plaque rupture or erosion. The major determinants of plaque vulnerability seem to be the size of the necrotic core and the thickness of the fibrous cap. However, because of the complexity of the processes leading to plaque vulnerability and susceptibility to thrombosis, trying to predict the fate and clinical impact of a particular plaque may be futile. Combining knowledge of risk factors and detection of overall disease burden, and treating patients who are at highest risk, may be the best strategy for this systemic disease. Inflammatory activity is present in most, or all, atherosclerotic lesions within the body and might therefore be a useful marker of systemic disease activity. Additionally, focal calcifications are very common in atherosclerotic plaques, and the total amount of coronary artery calcium correlates strongly with plaque burden and is a strong predictor of coronary events.